Patrick Jeanmonod - Net Worth and Insider Trading

Patrick Jeanmonod Net Worth

The estimated net worth of Patrick Jeanmonod is at least $493,152 dollars as of 2024-11-05. Patrick Jeanmonod is the CFO of Cytek Biosciences Inc and owns about 93,400 shares of Cytek Biosciences Inc (CTKB) stock worth over $493,152. Details can be seen in Patrick Jeanmonod's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick Jeanmonod has not made any transactions after 2023-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Patrick Jeanmonod

To

Patrick Jeanmonod Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick Jeanmonod owns 1 companies in total, including Cytek Biosciences Inc (CTKB) .

Click here to see the complete history of Patrick Jeanmonod’s form 4 insider trades.

Insider Ownership Summary of Patrick Jeanmonod

Ticker Comapny Transaction Date Type of Owner
CTKB Cytek Biosciences Inc 2023-12-26 Chief Financial Officer

Patrick Jeanmonod Latest Holdings Summary

Patrick Jeanmonod currently owns a total of 1 stock. Patrick Jeanmonod owns 93,400 shares of Cytek Biosciences Inc (CTKB) as of December 26, 2023, with a value of $493,152.

Latest Holdings of Patrick Jeanmonod

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CTKB Cytek Biosciences Inc 2023-12-26 93,400 5.28 493,152

Holding Weightings of Patrick Jeanmonod


Patrick Jeanmonod Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick Jeanmonod has made a total of 18 transactions in Cytek Biosciences Inc (CTKB) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Cytek Biosciences Inc is the sale of 3,000 shares on December 26, 2023, which brought Patrick Jeanmonod around $28,500.

Insider Trading History of Patrick Jeanmonod

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick Jeanmonod Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Patrick Jeanmonod Ownership Network

Ownership Network List of Patrick Jeanmonod

No Data

Ownership Network Relation of Patrick Jeanmonod

Insider Network Chart

Patrick Jeanmonod Owned Company Details

What does Cytek Biosciences Inc do?

Who are the key executives at Cytek Biosciences Inc?

Patrick Jeanmonod is the Chief Financial Officer of Cytek Biosciences Inc. Other key executives at Cytek Biosciences Inc include director & Chief Technology Officer Ming Yan , director & President and CEO Wenbin Jiang , and SVP & Global Sales and Services Philippe Busque .

Cytek Biosciences Inc (CTKB) Insider Trades Summary

Over the past 18 months, Patrick Jeanmonod made 8 insider transaction in Cytek Biosciences Inc (CTKB) with a net sale of 24,000. Other recent insider transactions involving Cytek Biosciences Inc (CTKB) include a net sale of 221,900 shares made by Ming Yan , a net sale of 140,000 shares made by Wenbin Jiang ,

In summary, during the past 3 months, insiders sold 0 shares of Cytek Biosciences Inc (CTKB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 385,900 shares of Cytek Biosciences Inc (CTKB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 385,900 shares.

Cytek Biosciences Inc (CTKB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cytek Biosciences Inc Insider Transactions

No Available Data

Patrick Jeanmonod Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick Jeanmonod. You might contact Patrick Jeanmonod via mailing address: C/o Cytek Biosciences, Inc., 46107 Landing Parkway, Fremont Ca 94538.